Shortcuts, coverups in drug plants often precede quality problems, shortages (By: Mary Van Beusekom, MS)
When US Food and Drug Administration (FDA) inspectors visited Integra LifeSciences' drug manufacturing facility in Boston in March through May, the company's collagen-based Durepair product failed bacterial endotoxin testing. The FDA issued a warning letter to the…









